Top compounds associated with response to MTRNR2L12


Feature Type Standardized
Nominal ANOVA
mRNA SMER-3 CTRPv2 pan-cancer AAC -0.079 0.03
mRNA Erlotinib CTRPv2 pan-cancer AAC 0.07 0.04
mRNA AA-COCF3 CTRPv2 pan-cancer AAC -0.067 0.06
mRNA CD-1530 CTRPv2 pan-cancer AAC -0.069 0.07
mRNA SNX-2112:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.058 0.07
mRNA JQ-1:vorinostat (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.059 0.07
mRNA SR8278 CTRPv2 pan-cancer AAC -0.31 0.07
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.062 0.08
mRNA cyanoquinoline 11 CTRPv2 pan-cancer AAC -0.087 0.08
mRNA erlotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.064 0.08
Download CSV